The BMI Clinic
The BMI Clinic is an Australian private healthcare clinic that delivers surgical, endoscopic, and lifestyle-program-based weight loss treatments to adults with obesity and weight-related comorbidities from three Australian locations. It pioneered Spatz3 and Endoscopic Sleeve Gastroplasty in Australia and pairs procedures with tiered multidisciplinary support programs.
- Company typePrivate
- Founded2005
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2C
- OfferingServices
What The BMI Clinic does
The BMI Clinic is an Australian private healthcare clinic founded in 2005 (originally as Gastric Balloon Australia by Prof. George Marinos) that specialises in medical, endoscopic, and surgical weight loss treatments for adults with obesity and weight-related comorbidities. Operating from three locations — Sydney Double Bay, Sydney Liverpool, and Melbourne (opened 2023) — and supported by telehealth consultations for interstate patients, the clinic is led medically by Dr. Adrian Sartoretto (Medical Director, who performed Australia's first Endoscopic Sleeve Gastroplasty in 2016) and a multidisciplinary team of bariatric specialists, dietitians, behavioural coaches, and exercise specialists.
The clinic's core technology spans a full procedure menu: intragastric balloons (Allurion swallowable balloon, Orbera fixed balloon, Spatz3 adjustable balloon — Australia's first and only adjustable 12-month balloon since 2014, with 6,000+ procedures performed), Endoscopic Sleeve Gastroplasty (ESG, non-surgical, performed entirely via the mouth and reducing stomach volume by ~75%), Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y and Mini Gastric Bypass, Adjustable Gastric Banding, and the TORe endoscopic revision procedure. These are paired with tiered lifestyle support programs (Silver, Gold, Platinum) of dietitian, exercise, and behavioural coaching consultations, and supported by custom-built proprietary patient monitoring software, Wi-Fi-enabled Allurion smart scales, DEXA body-composition scanning, and exclusive post-procedure IV hydration via a partnership with The Infusion Clinic.
The BMI Clinic generates revenue from per-procedure fees bundled with lifestyle program tiers, plus standalone lifestyle programs, weight loss medications, and supplementary clinical-trial revenue (e.g., the sponsor-funded PANORAMIC Study for Type 2 Diabetes). Pricing is not publicly disclosed; only LSG and Gastric Bypass qualify for private health insurance rebates, while balloons and ESG are self-funded with patient financing facilitated through Zip Money, TLC, MediPay, and Access My Super (early superannuation release). The go-to-market is sales-led, anchored by a free information call as the low-friction conversion point, complemented by content marketing, social media, patient testimonials, and clinical-trial recruitment.
The BMI Clinic firmographics
Firmographics- Name
- The BMI Clinic
- Legal name
- The BMI Clinic
- Website
- https://bmiclinic.com.au
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The BMI Clinic is an Australian private healthcare clinic that delivers surgical, endoscopic, and lifestyle-program-based weight loss treatments to adults with obesity and weight-related comorbidities from three Australian locations. It pioneered Spatz3 and Endoscopic Sleeve Gastroplasty in Australia and pairs procedures with tiered multidisciplinary support programs.
- Ownership category
- akta.pro rank
The BMI Clinic industry classification
Industry- Product category
- Bariatric & Weight Loss Clinic Services
- NAICS
- Freestanding Ambulatory Surgical and Emergency Centers (621493), Diet and Weight Reducing Centers (812191)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Obesity Medicine & Weight Management (HLAKADAL)
- akta.pro secondary industries
- General Gastroenterology (HLAKAEAA), General Nutrition Coaching (HSADAFAA)
Keywords
Where The BMI Clinic is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
The BMI Clinic business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Weight Loss Procedures and Programs: The BMI Clinic generates revenue from a suite of weight loss procedures including intragastric balloons (Allurion, Orbera, Spatz3), Endoscopic Sleeve Gastroplasty (ESG), Laparoscopic Sleeve Gastrectomy (LSG), Gastric Bypass (Roux-en-Y and Mini), and Adjustable Gastric Banding. Each procedure is paired with a tiered lifestyle support program (Silver, Gold, or Platinum) that includes consultations with dietitians, behavioural coaches, exercise specialists, and bariatric physicians. The clinic also offers standalone Lifestyle Weight Loss Programs and weight loss medications.
- Lifestyle and Support Programs: All procedures are accompanied by a comprehensive support program bundled into tiers (Silver, Gold, Platinum). These programs provide ongoing dietitian, behavioural, exercise specialist, and bariatric physician consultations over the program duration. The more consultations a patient has, the greater the weight loss outcome (data shows an extra 0.4kg per additional consultation), making the program a recurring engagement model throughout the patient's weight loss journey.
- Payment Plan Financing: The clinic offers multiple third-party financing options to patients: Zip Money (12 months interest-free for amounts under $15,000), TLC Total Lifestyle Credit (interest rates from 6.45%, loans from $2,001 to $50,000), and MediPay (11.99%-21.99% per annum). These financing arrangements facilitate higher procedure uptake by distributing costs over time.
- Early Superannuation Release Assistance: The clinic partners with Access My Super to assist patients in obtaining early release of superannuation to fund weight loss treatment, subject to ATO criteria (weight-related pain requirements). A $499 fee is payable to Access My Super for processing this service.
- Clinical Trial Conduct: The clinic conducts clinical trials (e.g., PANORAMIC Study for Type 2 Diabetes, HybridAPC in GMA Clinical Trial) sponsored by external organisations. Treatment costs are covered or subsidised by trial sponsors, and participants receive stipends for travel and time. This represents a research services revenue stream funded by external sponsors such as Ascend Clinical Research Organisation Pty Ltd.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Silver, Gold, and Platinum tiers accompany all procedures (gastric balloons, ESG, LSG, Gastric Bypass), with increasing levels of allied health support and consultations |
| One time/ perpetual license | Multi-year contract | Laparoscopic Sleeve Gastrectomy (LSG) and Gastric Bypass procedures may be partially covered by private health insurance for hospital fees |
| Transaction based/ take rate | Monthly | Zip Money allows patients to spread procedure costs over 12 months interest-free (under $15,000) or 36 months at standard variable rate |
| Transaction based/ take rate | Monthly | TLC (Total Lifestyle Credit) offers loans from $2,001 to $50,000 with interest rates from 6.45% and up to 84-month terms |
| Transaction based/ take rate | Monthly | MediPay provides financing at 11.99%-21.99% per annum with 48-month payment terms and establishment fees from $140 to $595 |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels8 records
The BMI Clinic product offering
Product offeringCore offering
The BMI Clinic delivers bariatric and endoscopic weight loss procedures — including gastric balloons (Spatz3, Allurion, Orbera), Endoscopic Sleeve Gastroplasty (ESG), Laparoscopic Sleeve Gastrectomy (LSG), Adjustable Gastric Banding, and Roux-en-Y and Mini Gastric Bypass — bundled with tiered lifestyle support programs (Silver, Gold, Platinum) involving dietitians, behavioural coaches, exercise specialists, and bariatric physicians. It also runs lifestyle-only weight management programs and conducts sponsored clinical trials in metabolic health.
Product overview
The BMI Clinic is Australia's leading weight loss clinic offering a comprehensive portfolio of both non-surgical and surgical weight loss procedures. The non-surgical offerings include gastric balloons (Spatz3 Adjustable, Allurion, and Orbera) and Endoscopic Sleeve Gastroplasty (ESG), while surgical options include Adjustable Gastric Banding, Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass, and Mini Gastric Bypass. All procedures are accompanied by a holistic Lifestyle Program providing multidisciplinary support including dietitians, exercise specialists, and behavioural coaches. The clinic also conducts clinical trials including the PANORAMIC Study for Type 2 Diabetes and HybridAPC in GMA study. Treatment tiers include Silver, Gold, and Platinum programs offering different levels of support and follow-up care.
Differentiator
Problem solved
Functional benefit
Brands
- Allurion: Swallowable gastric balloon program offered at The BMI Clinic.
- Orbera
- Spatz3
- PANORAMIC Study
Products and services
- Spatz3 Adjustable Intragastric Balloon The only 12-month gastric balloon approved for use in Australia and the only adjustable gastric balloon worldwide. It is implanted without surgery and stays for up to 12 months, with adjustable size to maximise weight loss outcomes for adults with overweight or obesity.
- Allurion Gastric Balloon A swallowable gastric balloon option that helps patients feel full sooner and longer, manage hunger, adopt healthy habits, and naturally reduce portions through a 6-month program, for adults seeking non-surgical weight loss.
- Orbera Gastric Balloon A soft, silicone balloon implanted in the stomach without surgery for up to 6 months to help reduce hunger and portion sizes, achieving an average of 12% total body weight loss for adults with overweight or obesity.
- Endoscopic Sleeve Gastroplasty (ESG) A revolutionary non-surgical procedure performed entirely through the mouth, reducing stomach size by approximately 75% through internal sutures, resulting in 20-25% total body weight loss for adults seeking non-surgical bariatric intervention.
- Laparoscopic Sleeve Gastrectomy (LSG) / Gastric Sleeve Surgery Surgical procedure that removes a large portion of the stomach along the greater curve, reducing stomach volume by approximately 85%, resulting in 20-30% total body weight loss for adults with obesity.
- Adjustable Gastric Banding Surgery A minimally invasive surgical procedure involving placement of an inflatable silicone ring around the upper part of the stomach via laparoscopic (keyhole) surgery for adults with obesity.
- Roux-en-Y Gastric Bypass A surgical procedure that divides the stomach into a small pouch about the size of a walnut and diverts food around the first part of the intestine, resulting in 25-30% total body weight loss for adults with obesity.
- Mini Gastric Bypass A surgical weight loss procedure that creates a smaller stomach pouch and reroutes the intestine, resulting in 30-35% total body weight loss for adults with obesity.
- TORe Gastric Bypass Revision Transoral Outlet Revision — an endoscopic suturing procedure performed on patients who have had a gastric bypass to revise the outlet if it has stretched over time, for adults experiencing weight regain after prior bariatric surgery.
- Lifestyle Weight Loss Program A comprehensive, best-practice weight management program backed by the latest weight loss science and an integrated team of bariatric doctors, dietitians, exercise specialists and behavioural coaches, offered both standalone and bundled with procedures in Silver, Gold, and Platinum tiers.
- PANORAMIC Study (Duodenal Mucosal Regeneration Clinical Trial) Clinical research study evaluating a new minimally invasive procedure called Duodenal Mucosal Regeneration (DMR) for adults living with Type 2 Diabetes, targeting the lining of the duodenum to help regenerate healthier tissue; treatment costs covered or subsidised by sponsor.
- HybridAPC in GMA Clinical Trial First-in-human clinical study investigating the safety and feasibility of a new potential treatment for weight loss using the Gastric Mucosal Ablation (GMA) Procedure for adults with obesity.
Quantifiable outcome
- Spatz3 patients at The BMI Clinic achieve 18.2% average total body weight loss vs 16.4% in other published studies — a 10%+ relative improvement
- +6 more outcomes
Companies that use The BMI Clinic
Customer profileNamed customers12 records
Segments2 records
Ideal customer profiles2 records
The BMI Clinic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature5 records
The BMI Clinic partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- The Infusion CliniccoreThe Infusion Clinic is a partner organisation providing exclusive IV hydration and medication services to The BMI Clinic's patients post-procedure. Dr. Adrian Sartoretto holds Medical Director positions with both The BMI Clinic and The Infusion Clinic, indicating a shared leadership connection. This partnership enables the clinic's fast recovery protocols, with patients receiving IV hydration and medications in the days following procedures to minimise symptoms and optimise recovery.
- The Australian Breath Analysis LaboratoryminorThe Australian Breath Analysis Laboratory is a related entity under Dr. Adrian Sartoretto's Medical Director oversight. This laboratory may support the clinic's metabolic and clinical research activities, though specific details of the partnership are not extensively detailed in available sources.
Scale indicators10 records
Recent moves9 records
Expansion highlights7 records
The BMI Clinic competitors and assessment
Company assessmentOthers
- Allurion Technologies: US-based company behind the swallowable Allurion gastric balloon program offered at The BMI Clinic. Supplier/ecosystem partner whose commercial trajectory directly affects The BMI Clinic's Allurion revenue line.
- Apollo Endosurgery: US-listed medical device company that manufactures the Orbera intragastric balloon and OverStitch endoscopic suturing system used in ESG. Indirect comparator as the upstream technology supplier enabling The BMI Clinic's endoscopic procedures.
- Spatz Medical: Manufacturer of the Spatz3 adjustable gastric balloon, in which The BMI Clinic is Australia's largest and most experienced provider (6,000+ procedures since 2014). Supplier/ecosystem partner whose regulatory and product roadmap underpins a major portion of the clinic's procedure volume.
Emerging players
- Juniper: Australian telehealth weight loss platform offering medically supervised GLP-1 medication programs. Targets the same obese Australian demographic via a lower-friction, non-surgical delivery model and represents the medication-first competitive threat.
- Eucalyptus (formerly Pilot): Australian digital health platform running multiple condition-specific telehealth clinics including a weight loss offering. Competes for the same Australian obesity patients via subscription telehealth and prescription medications.
Direct peers
- SmartShape Weight Loss Centre: Australian bariatric clinic offering gastric sleeve, gastric bypass, and gastric banding surgery with bundled aftercare programs. Direct competitor in the same Sydney/Melbourne patient pool and procedure mix.
- Newcastle Obesity Centre: Australian specialist obesity clinic providing surgical and endoscopic weight loss procedures including gastric balloons, sleeve gastrectomy, and gastric bypass. Comparable patient demographic and multidisciplinary service model.
- Bariatric Solutions Australia: Australian bariatric provider offering gastric sleeve, bypass, banding and intragastric balloon procedures with program-based support. Competes for the same medically-supervised weight loss patient segment in Australia.
Broad incumbents
- Healthscope (Bariatric Surgery): Major Australian private hospital operator offering bariatric surgery across multiple sites. Large incumbent with overlapping surgical offerings but without The BMI Clinic's endoscopic specialisation (ESG, intragastric balloons).
- Ramsay Health Care Australia (Bariatric Services): Large Australian private hospital network that performs bariatric surgery (sleeve gastrectomy and gastric bypass) as part of a broader multi-specialty surgical offering. Provides similar surgical procedures but as one service line within a diversified hospital portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
The BMI Clinic social profiles
Digital presenceThe BMI Clinic financial estimates
Financial estimateRevenue estimate
Valuation estimate
The BMI Clinic leadership team
Management profileNumber of profiles
Profiles4 records
The BMI Clinic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The BMI Clinic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The BMI Clinic
What does The BMI Clinic do?
The BMI Clinic delivers bariatric and endoscopic weight loss procedures — including gastric balloons (Spatz3, Allurion, Orbera), Endoscopic Sleeve Gastroplasty (ESG), Laparoscopic Sleeve Gastrectomy (LSG), Adjustable Gastric Banding, and Roux-en-Y and Mini Gastric Bypass — bundled with tiered lifestyle support programs (Silver, Gold, Platinum) involving dietitians, behavioural coaches, exercise specialists, and bariatric physicians. It also runs lifestyle-only weight management programs and conducts sponsored clinical trials in metabolic health.
Is The BMI Clinic a public or private company?
The BMI Clinic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was The BMI Clinic founded?
The BMI Clinic was founded in 2005. It employs 11 to 50 people.
Where is The BMI Clinic based?
The BMI Clinic is headquartered in Sydney, Australia, in the Oceania region.
How does The BMI Clinic make money?
Five revenue lines are on record. Weight Loss Procedures and Programs are the primary driver. The others are lifestyle and Support Programs, payment Plan Financing, early Superannuation Release Assistance and clinical Trial Conduct.
Who are The BMI Clinic's main competitors?
Others on record are Allurion Technologies, Apollo Endosurgery and Spatz Medical. Emerging players are Juniper and Eucalyptus (formerly Pilot). Direct peers are SmartShape Weight Loss Centre, Newcastle Obesity Centre and Bariatric Solutions Australia. Broad incumbents are Healthscope (Bariatric Surgery) and Ramsay Health Care Australia (Bariatric Services).
Does The BMI Clinic have an API?
No public API is recorded for The BMI Clinic.
What industry is The BMI Clinic in?
The BMI Clinic's product category is Bariatric & Weight Loss Clinic Services. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management, with a secondary code of HLAKAEAA, General Gastroenterology. Its NAICS code is 621493 and its SIC code is 8093.